Avista Acquisition Corp. 4

4 · Avista Healthcare Public Acquisition Corp. · Filed Nov 1, 2018

Insider Transaction Report

Form 4
Period: 2018-10-30
Transactions
  • Other

    Class B Ordinary Shares

    2018-10-30+26,9844,296,359 total
    Class A Ordinary Shares (26,984 underlying)
Footnotes (5)
  • [F1]Pursuant to the Amended and Restated Memorandum and Articles of Association (the "Articles") of the Issuer, the Class B ordinary shares, par value $0.0001 per share (the "Class B Shares") will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's Business Combination, as defined in the Articles, on a one-for-one basis, subject to adjustment, and have no expiration date.
  • [F2]Represents 7,158 Class B ordinary shares received by Avista Acquisition Corp. (the "Sponsor") from each of Hakan Bjorklund, Charles Harwood and Robert O'Neil and 5,510 Class B ordinary shares received from Brian Markison, in each case, for no consideration.
  • [F3]Directly owned by Sponsor. The sole shareholder of Sponsor is Avista Acquisition, LLC ("Avista Acquisition"). Thompson Dean and David Burgstahler are the managers of Avista Acquisition (and, together with Sponsor, Avista Acquisition, Messrs. Dean and Burgstahler are the "Reporting Persons").
  • [F4]Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
  • [F5]Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Documents

2 files